Literature DB >> 11953381

Evidence for the emergence of non-O1 and non-O139 Vibrio cholerae strains with pathogenic potential by exchange of O-antigen biosynthesis regions.

Manrong Li1, Toshio Shimada, J Glenn Morris, Alexander Sulakvelidze, Shanmuga Sozhamannan.   

Abstract

The novel epidemic strain Vibrio cholerae O139 Bengal originated from a seventh-pandemic O1 El Tor strain by antigenic shift resulting from homologous recombination-mediated exchange of O-antigen biosynthesis (wb*) clusters. Conservation of the genetic organization of wb* regions seen in other serogroups raised the possibility of the existence of pathogenic non-O1 and non-O139 V. cholerae strains that emerged by similar events. To test this hypothesis, 300 V. cholerae isolates of non-O1 and non-O139 serogroups were screened for the presence of virulence genes and an epidemic genetic background by DNA dot blotting, IS1004 fingerprinting, and restriction fragment length polymorphism (RFLP) analysis. We found four non-O1 strains (serogroups O27, O37, O53, and O65) with an O1 genetic backbone suggesting exchange of wb* clusters. DNA sequence analysis of the O37 wb* region revealed that a novel approximately 23.4-kb gene cluster had replaced all but the approximately 4.2-kb right junction of the 22-kb O1 wbe region. In sharp contrast to the backbones, the virulence regions of the four strains were quite heterogeneous; the O53 and O65 strains had the El Tor vibrio pathogenicity island (VPI) cluster, the O37 strain had the classical VPI cluster, and the O27 strain had a novel VPI cluster. Two of the four strains carried CTXphi; the O27 strain possessed a CTXphi with a recently reported immune specificity (rstR-4** allele) and a novel ctxB allele, and the O37 strain had an El Tor CTXphi (rstR(ET) allele) and novel ctxAB alleles. Although the O53 and O65 strains lacked the ctxAB genes, they carried a pre-CTXphi (i.e., rstR(cla)). Identification of non-O1 and non-O139 serogroups with pathogenic potential in epidemic genetic backgrounds means that attention should be paid to possible future epidemics caused by these serogroups and to the need for new, rapid vaccine development strategies.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11953381      PMCID: PMC127942          DOI: 10.1128/IAI.70.5.2441-2453.2002

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  55 in total

1.  Virus on virus infects bacterium.

Authors:  R K Taylor
Journal:  Nature       Date:  1999-05-27       Impact factor: 49.962

2.  Cloning and sequencing of the genes downstream of the wbf gene cluster of Vibrio cholerae serogroup O139 and analysis of the junction genes in other serogroups.

Authors:  S Sozhamannan; Y K Deng; M Li; A Sulakvelidze; J B Kaper; J A Johnson; G B Nair; J G Morris
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

3.  Molecular characterization of a new variant of toxin-coregulated pilus protein (TcpA) in a toxigenic non-O1/Non-O139 strain of Vibrio cholerae.

Authors:  B Nandi; R K Nandy; A C Vicente; A C Ghose
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

4.  The Vibrio cholerae O139 Calcutta bacteriophage CTXphi is infectious and encodes a novel repressor.

Authors:  B M Davis; H H Kimsey; W Chang; M K Waldor
Journal:  J Bacteriol       Date:  1999-11       Impact factor: 3.490

5.  Alternative mechanism of cholera toxin acquisition by Vibrio cholerae: generalized transduction of CTXPhi by bacteriophage CP-T1.

Authors:  E F Boyd; M K Waldor
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

6.  A bacteriophage encoding a pathogenicity island, a type-IV pilus and a phage receptor in cholera bacteria.

Authors:  D K Karaolis; S Somara; D R Maneval; J A Johnson; J B Kaper
Journal:  Nature       Date:  1999-05-27       Impact factor: 49.962

7.  Infectious CTXPhi and the vibrio pathogenicity island prophage in Vibrio mimicus: evidence for recent horizontal transfer between V. mimicus and V. cholerae.

Authors:  E F Boyd; K E Moyer; L Shi; M K Waldor
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

8.  The genes responsible for O-antigen synthesis of vibrio cholerae O139 are closely related to those of vibrio cholerae O22.

Authors:  S Yamasaki; T Shimizu; K Hoshino; S T Ho; T Shimada; G B Nair; Y Takeda
Journal:  Gene       Date:  1999-09-17       Impact factor: 3.688

9.  Virulence genes in environmental strains of Vibrio cholerae.

Authors:  S Chakraborty; A K Mukhopadhyay; R K Bhadra; A N Ghosh; R Mitra; T Shimada; S Yamasaki; S M Faruque; Y Takeda; R R Colwell; G B Nair
Journal:  Appl Environ Microbiol       Date:  2000-09       Impact factor: 4.792

10.  DNA sequence of both chromosomes of the cholera pathogen Vibrio cholerae.

Authors:  J F Heidelberg; J A Eisen; W C Nelson; R A Clayton; M L Gwinn; R J Dodson; D H Haft; E K Hickey; J D Peterson; L Umayam; S R Gill; K E Nelson; T D Read; H Tettelin; D Richardson; M D Ermolaeva; J Vamathevan; S Bass; H Qin; I Dragoi; P Sellers; L McDonald; T Utterback; R D Fleishmann; W C Nierman; O White; S L Salzberg; H O Smith; R R Colwell; J J Mekalanos; J C Venter; C M Fraser
Journal:  Nature       Date:  2000-08-03       Impact factor: 49.962

View more
  32 in total

1.  Possible laboratory contamination leads to incorrect reporting of Vibrio cholerae O1 and initiates an outbreak response.

Authors:  Anthony M Smith; Karen H Keddy; Husna Ismail; Nomsa Tau; Arvinda Sooka; Brett N Archer; Juno Thomas; Noreen Crisp
Journal:  J Clin Microbiol       Date:  2011-12-07       Impact factor: 5.948

Review 2.  Biodiversity of vibrios.

Authors:  Fabiano L Thompson; Tetsuya Iida; Jean Swings
Journal:  Microbiol Mol Biol Rev       Date:  2004-09       Impact factor: 11.056

3.  RTX toxin actin cross-linking activity in clinical and environmental isolates of Vibrio cholerae.

Authors:  Christina L Cordero; Shanmuga Sozhamannan; Karla J Fullner Satchell
Journal:  J Clin Microbiol       Date:  2007-05-23       Impact factor: 5.948

Review 4.  Circulation and transmission of clones of Vibrio cholerae during cholera outbreaks.

Authors:  O Colin Stine; J Glenn Morris
Journal:  Curr Top Microbiol Immunol       Date:  2014       Impact factor: 4.291

5.  Genomic characterization of non-O1, non-O139 Vibrio cholerae reveals genes for a type III secretion system.

Authors:  Michelle Dziejman; Davide Serruto; Vincent C Tam; Derek Sturtevant; Pornphan Diraphat; Shah M Faruque; M Hasibur Rahman; John F Heidelberg; Jeremy Decker; Li Li; Kate T Montgomery; George Grills; Raju Kucherlapati; John J Mekalanos
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-22       Impact factor: 11.205

6.  Chironomid egg masses as a natural reservoir of Vibrio cholerae non-O1 and non-O139 in freshwater habitats.

Authors:  M Halpern; Y B Broza; S Mittler; E Arakawa; M Broza
Journal:  Microb Ecol       Date:  2003-12-23       Impact factor: 4.552

7.  Multilocus sequence typing has better discriminatory ability for typing Vibrio cholerae than does pulsed-field gel electrophoresis and provides a measure of phylogenetic relatedness.

Authors:  Mamuka Kotetishvili; O Colin Stine; Yuansha Chen; Arnold Kreger; Alexander Sulakvelidze; Shanmuga Sozhamannan; J Glenn Morris
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

8.  Genomic diversity of clinical and environmental Vibrio cholerae strains isolated in Brazil between 1991 and 2001 as revealed by fluorescent amplified fragment length polymorphism analysis.

Authors:  Fabiano L Thompson; Cristiane C Thompson; Ana C P Vicente; Grace N D Theophilo; Ernesto Hofer; Jean Swings
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

9.  The Hybrid Pre-CTXΦ-RS1 Prophage Genome and Its Regulatory Function in Environmental Vibrio cholerae O1 Strains.

Authors:  Hongxia Wang; Bo Pang; Lifeng Xiong; Duochun Wang; Xiaomei Wang; Lijuan Zhang; Biao Kan
Journal:  Appl Environ Microbiol       Date:  2015-08-07       Impact factor: 4.792

10.  Successful small intestine colonization of adult mice by Vibrio cholerae requires ketamine anesthesia and accessory toxins.

Authors:  Verena Olivier; Jessica Queen; Karla J F Satchell
Journal:  PLoS One       Date:  2009-10-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.